Long-term tumor control in Koos grade IV vestibular schwannomas without the need for gross-total resection

Michel Roethlisberger1,2, Giusi Moffa3, Jonathan Rychen1

  • 1Departments of1Neurosurgery and.

Journal of Neurosurgery
|December 1, 2023
PubMed
Abstract

Insights

Subtotal resection for large vestibular schwannomas followed by observation and radiation therapy for progression offers excellent tumor control and good facial nerve outcomes.

Area of Science:

  • Neurosurgery
  • Oncology
  • Otolaryngology

Background:

  • Management of Koos grade IV vestibular schwannomas (VSs) balances functional preservation with tumor control.
  • Gross-total resection (GTR) offers optimal tumor control but often results in permanent facial nerve (FN) palsy.
  • Subtotal resection (STR) or near-total resection (NTR) followed by observation and selective radiation therapy (RT) presents an alternative with potentially lower morbidity.

Purpose of the Study:

  • To evaluate the efficacy and safety of less-than-total resection for Koos grade IV VSs.
  • To assess tumor control rates and facial nerve function following STR/NTR and a wait-and-scan protocol.
  • To analyze the role of second-line RT for progressive tumor residuals.

Main Methods:

  • Prospective cohort study of 48 patients with Koos grade IV VSs undergoing less-than-total resection (Jan 2009-Dec 2019).
  • Follow-up included annual clinical assessments and volumetric MRI analyses.
  • Analysis of tumor residual behavior, progression-free survival, facial outcomes (House-Brackmann grade), and RT utilization.

Main Results:

  • Mean resection extent was 87% (STR).
  • Tumor residuals stabilized or regressed in 81% of patients at 4.4 years; 79% progression-free survival at 4 years.
  • Overall tumor control rate reached 96% after selective second-line RT for progression, with 92% achieving good facial outcomes (HB grade I/II).

Conclusions:

  • STR followed by observation and selective second-line RT is a viable strategy for Koos grade IV VSs.
  • This approach achieves excellent long-term tumor control while preserving facial nerve function.
  • It offers a favorable alternative to GTR, minimizing permanent morbidity.

Related Concept Videos